Li Xiang

Luzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

An integrated network toxicology and multi-omics study identifies ENO1 as a candidate mediator in benzo[a]pyrene-related gastric cancer progression.

An integrated network toxicology and multi-omics study identifies ENO1 as a candidate mediator in benzo[a]pyrene-related gastric cancer progression.

Journal: Frontiers in pharmacology
Published: April 16, 2026

Focusing on depressive symptoms in patients to mitigate the risk of pain: a nationwide, prospective cohort study.

Focusing on depressive symptoms in patients to mitigate the risk of pain: a nationwide, prospective cohort study.

Journal: BMC public health
Published: February 27, 2026

Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer.

Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer.

Journal: Frontiers in pharmacology
Published: February 05, 2026

Albumin-globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.

Albumin-globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.

Journal: Annals of medicine
Published: November 24, 2025

Role and Molecular Mechanisms of Aerobic Glycolysis in Gastrointestinal Tumors.

Role and Molecular Mechanisms of Aerobic Glycolysis in Gastrointestinal Tumors.

Journal: Journal of Cancer
Published: September 16, 2025

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.

Journal: Signal transduction and targeted therapy
Published: August 12, 2025

N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment.

N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment.

Journal: Frontiers in immunology
Published: July 13, 2024

Development of a neoadjuvant chemotherapy efficacy prediction model for nasopharyngeal carcinoma integrating magnetic resonance radiomics and pathomics: a multi-center retrospective study.

Development of a neoadjuvant chemotherapy efficacy prediction model for nasopharyngeal carcinoma integrating magnetic resonance radiomics and pathomics: a multi-center retrospective study.

Journal: BMC cancer
Published: June 22, 2024

Comprehensive analysis of the prognostic and immunological role of cavins in non-small cell lung cancer.

Comprehensive analysis of the prognostic and immunological role of cavins in non-small cell lung cancer.

Journal: BMC cancer
Published: December 19, 2023

Comprehensive analysis revealed P4Hs as new biomarkers for prognosis and immunotherapy in head and neck cancer.

Comprehensive analysis revealed P4Hs as new biomarkers for prognosis and immunotherapy in head and neck cancer.

Journal: Scientific reports
Published: November 30, 2023

SDPR Inhibits TGF-β Induced Cancer Metastasis Through Fatty Acid Oxidation Regulation in Gastric Cancer.

SDPR Inhibits TGF-β Induced Cancer Metastasis Through Fatty Acid Oxidation Regulation in Gastric Cancer.

Journal: International journal of biological sciences
Published: January 29, 2023

Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.

Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.

Journal: International journal of radiation oncology, biology, physics
Published: January 10, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026